FDA Extends Gingivitis Draft Guidance Comment Period To Oct. 28
This article was originally published in The Tan Sheet
Executive Summary
FDA will accept comments on a 1draft guidance addressing antigingivitis drug development and evaluation until Oct. 28, 2005, the agency said in an Aug. 24 Federal Register notice